Fingerprint
Dive into the research topics of 'Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers
Filip Janku, Divya Sakamuri, Shumei Kato, Helen J. Huang, S. Greg Call, Aung Naing, Veronica R. Holley, Sapna P. Patel, Rodabe N. Amaria, Gerald S. Falchook, Sarina A. Piha-Paul, Ralph G Zinner, Apostolia M. Tsimberidou, David S. Hong, Funda Meric-Bernstam
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations